Pablo Gil-Perez, Juan Miguel Ruiz-Nodar, María Asunción Esteve-Pastor, Ignacio Hortelano, Beatriz Villamía, Nuria Vicente-Ibarra, Esteban Orenes-Piñero, Manuel Jesús Macías, Laura Núñez-Martínez, Luna Carrillo, Elena Candela, Andrea Véliz-Martínez, Cecilia López-García, Juan Gabriel Martínez-Martínez, José Miguel Rivera-Caravaca, Francisco Marín
AIMS: We investigated the impact of diabetes mellitus (DM) in acute coronary syndrome (ACS) patients, and the 2-year prognosis based on antiplatelet therapy. METHODS: This is a prospective and multicenter registry including hospitalized ACS patients. Clinical management and antiplatelet therapy at discharge were recorded. Bleeding events, all-cause mortality and major adverse cardiovascular events (MACEs) were recorded during 2-years and compared according to DM and the P2Y12 receptor inhibitor...
January 24, 2022: Diabetes Research and Clinical Practice